A global virtual event dedicated to the latest cardio-renal-metabolic disease treatment strategies to support better patient outcomes
A global virtual event dedicated to the latest cardio-renal-metabolic disease treatment strategies to support better patient outcomes
KDIGO and Translational Medicine Academy (TMA), in partnership with Radcliffe Cardiology, are excited to announce e-SPACE Cardio-Renal-Metabolic (CRM), taking place 10–11 April 2026.
Cardio-kidney-metabolic (CKM) health reflects the complex interactions between metabolic risk factors, diabetes, chronic kidney disease and the cardiovascular system – major drivers of global morbidity and mortality. To address these challenges, TMA and KDIGO’s e-SPACE CRM programme empowers clinicians worldwide to improve patient outcomes.
The 2026 conference offers free, cutting-edge virtual education, uniting leaders in cardiology, nephrology and diabetology. Participants can engage through concise expert talks, live panels and interactive “meet the expert” sessions, blending global and regional insights.
Following the success of e-SPACE CRM 2025, which brought together 60 experts and almost 3,000 healthcare professionals, the 2026 event will advance professional development and support KDIGO’s mission to improve kidney care globally.
Guided by an esteemed international faculty and TMA’s educational expertise, e-SPACE CRM 2026 is set to be a leading online conference for the cardio-renal-metabolic community.
Watch e-SPACE CRM 2025 on-demand here.
(Please note this programme is subject to change)
Day 1
Keynote Session
Keynote Lecture
Meet the Experts
Meet the Experts
Plenary Session
Session 1 – Optimising Outcomes for Patients With Cardio-Renal-Metabolic (CRM) Disease
Chairs – Andrew Coats and Manisha Sahay
The Urgency and Rationale of Addressing CRM in Our Patients – Brendon Neuen
The Role of Primary Care – Ana Cebrián Cuenca
Staging CKM Disease – Merlin Thomas
The Role of Imaging – Victoria Delgado
Panel Discussion
Meet the Experts
Meet the Experts
Plenary Session
Session 2 – Evolving Guidelines in CKM
Chair – Christoph Wanner
Integrated Care: The Rationale for Simpler, Unified Guidelines – Joao Ferreira
Standards of Care in Diabetes 2026: Chronic Kidney Disease and Risk Management – Sylvia Rosas
KDIGO Update: New Perspectives in Kidney Health
iCardio Guidelines: Global Cascade Guidelines on Obesity and HF – Vijay Chopra
Assessing Metabolic Disorders: The EAS Perspective – Stefano Romeo
Panel Discussion
Keynote Session
Keynote Lecture
Meet the Experts
Meet the Experts
Plenary Session
Session 3 – Foundational (and Almost Foundational) Therapies in CRM
Chairs – Antonio Ceriello and Nisha Bansal
SGLT2 Inhibitors – Nisha Bansal
MRAs?! – Maja Cikes
GLP1 RA?! – Naveed Sattar
ASI – Shahzeb Khan
Panel Discussion
Meet the Experts
Meet the Experts
Plenary Session
Session 4 – Anti-Obesity Medication (AOMs) Clinical Experience
Chairs – Marc-André Cornier and James Burton
The Nephrologist View
The Diabetologist View – Jennifer Green
The Cardiologist View – Javed Butler
Muscle-Wasting Associated With AOMs – Stefan Anker
Panel Discussion
Meet the Experts
Meet the Experts
Plenary Session
Session 5 – Non-Steroidal MRAs
Chair – Nisha Bansal
Non-Steroidal vs. Steroidal MRAs – What Clinicians Need to Know
Finerenone in CKD: Managing Patients at High Risk of Heart Failure
Expanding the Spectrum: Finerenone in Heart Failure Across CKM Risk Profiles – Justin Ezekowitz
Expanding the Spectrum: Finerenone in T1D – Hiddo Heerspink
Panel Discussion
Meet the Experts
Meet the Experts
Plenary Session
Session 6 – Improving Outcomes in HFpEF: New Frontiers
Chairs – Barry Borlaug
What is HFpEF? – John McMurray
Obesity is HFpEF & HFpEF is Obesity?! – Milton Packer
Diagnostic Challenges: Identifying HFpEF in Clinical Practice – Cristina Gavina
Management Strategies: Current and Emerging Therapies
Panel Discussion
Day 2
Meet the Experts
Meet the Experts
Plenary Session
Session 7 – Obesity as a Central Player in CRM
Chairs – Carel Le Roux and Carol Pollock
Clinical Frameworks: Recent Definitions and Evolving Classifications of Obesity
The Kidney and Obesity: Mechanisms of Renal Injury
Type 2 Diabetes and Obesity
Sarcopenic Obesity – Stephan von Haehling
Panel Discussion
Meet the Experts
Meet the Experts
Plenary Session
Session 8 – Managing Key Parameters in CRM
Chair – Shazeb Khan
Potassium Levels – Patrick Rossignol
Albuminaria – David Wheeler
NT ProBNPs – Evangelos Giannitsis
Low eGFR – James Burton
Low Sodium – Julio Núñez
Lipids – Pierre François Sabouret
Panel Discussion
Meet the Experts
Meet the Experts
Plenary Session
Session 9 – Combination Therapies for CKM
Chair – Giuseppe Rosano
Synergistic Effects: Combination Therapy With Finerenone and Empagliflozin – Jennifer Green
The EASi-KIDNEY Trial: New Evidence in Renal Protection
The Polypill: Can Simplification Change the Treatment Landscape? – Piotr Ponikowski
Combining Incretins With Muscle Anabolics – Stefan Anker
Panel Discussion
Meet the Experts
Meet the Experts
Plenary Session
Session 10 – From Prevention to Shared Decision-Making
Chair – Fausto Pinto
Cardiometabolic Health in the Course of Women’s Life – Glaucia Moraes de Oliveira
Implementation Science in the Path Toward Pharmacoequity – Dinushika Mohottige
The LATTICE Initiative – Ankeet Bhatt
Panel Discussion
Joao Ferreira
Course Director
University of Porto, Porto, PT
Shahzeb Khan
Course Director
Baylor Scott & White Health, Dallas, US
Shelley Zieroth
Course Director
University of Manitoba, Winnipeg, CA
Faculty
Stefan Anker
Charité Campus Virchow-Klinikum, Berlin, DE
Nisha Bansal
University of Washington, Seattle, US
Ankeet Bhatt
Kaiser Permanente San Francisco Medical Center, San Francisco, US
Barry Borlaug
Mayo Clinic and Foundation, Rochester, US
James Burton
University of Leicester, Leicester, UK
Javed Butler
University of Mississippi Medical Center, Jackson, US
Ana Maria Cebrián Cuenca
Centro de Salud San Antón, Murcia, ES
Antonio Ceriello
IRCCS MultiMedica, Milan, IT
Andrew Coats
Monash University, Melbourne, AU
Marc-Andre Cornier
Medical University of South Carolina, Charleston, US
Justin Ezekowitz
University of Alberta, Edmonton, CA
Cristina Gavina
University of Porto, Porto, PT
Jennifer Green
Duke Clinical Research Institute, Durham, US
Hiddo Heerspink
University Medical Center Groningen, Groningen, NL
Carel Le Roux
University College Dublin, Dublin, IE
John McMurray
University of Glasgow, Glasgow, UK
Milton Packer
Baylor University Medical Center, Texas, US
Fausto Pinto
Santa Maria Hospital - CHULN, Lisbon, PT
Carol Pollock
The University of Sydney, Camperdown, AU
Stefano Romeo
University of Gothenburg, Gothenburg, SE
Patrick Rossignol
CHRU de Nancy, Nancy, FR
Manisha Sahay
Osmania General Hospital, Hyderabad, IN
Merlin Thomas
Monash University, Melbourne, AU
-
Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality and reduced quality of life affecting individuals around the world
-
Describe the complexity and interlink between the three conditions
-
Discuss existing guidelines and best approaches for screening patients
-
Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease and obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
-
Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes
-
Cardiologists
-
Nephrologists
-
Diabetologists
-
General Practitioners (GPs)
-
HF Specialists
-
Nurses, Pharmacists and other Allied Healthcare Professionals
If you’re interested in becoming an educational partner or sponsor at this event, please contact [email protected]
About KDIGO
KDIGO is a global organisation developing and implementing evidence-based clinical practice guidelines in kidney disease. It is an independent, volunteer-led, self-managed foundation incorporated in Belgium and accountable to the public and the patients it serves.
KDIGO’s mission is to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines.
For more information on KDIGO, please visit https://kdigo.org.
About Translational Medicine Academy
Our ambition at the Translational Medicine Academy® (TMA) is to bring medical findings from bench to bedside and into the working lives of physicians and the care of patients. In seeking to improve therapeutic approaches, TMA works with its International Scientific Advisory Board on Critical Mission Areas® of public health importance in domains where there are educational shortcomings among physicians and unmet healthcare needs among patients.
Gathered around a Scientific Advisory Board of experts, the Translational Medicine Academy is an international non-profit Foundation with headquarter in Basel, and offices in Paris, and the US. TMA’s funding includes private donations from individuals and educational grants from governments, non-governmental organizations and corporations.
For more information on TMA, please visit www.tmacademy.org.
About Radcliffe Cardiology
We are Radcliffe, a knowledge network for the cardiovascular community
We’re here to bring cardiovascular knowledge, insight and innovation to life for clinicians around the world, using our communications and creative expertise, our platforms and connections across the community to help transform theory into practice faster and more effectively.
We bring medical knowledge to life
From great science writing and smart journal editing, the curation of evidence based and peer-reviewed content, to engaging new formats that cut through the noise, we believe that communication is at the heart of great healthcare.
Our work is underpinned by 3 core principles:
-
We build on the best science
-
We work hands-on with our community
-
We bring fresh thinking
Our promise is that we’ll equip you with the latest knowledge and skills you need, to do the best for your patients.
For more information on Radcliffe Cardiology, please visit www.radcliffecardiology.com.
Please contact [email protected] should you have any queries.



